Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	639	500	608	185	384	275
Market Cap Growth	77.61%	-17.77%	229.29%	-51.88%	39.68%	-77.81%
Enterprise Value	489	332	557	64	229	160
PE Ratio	-	-8.70	-3.76	-1.51	-2.56	-1.42
PS Ratio	5.66	4.42	166.71	4.51	19.12	17.20
PB Ratio	25.18	12.62	-13.49	5.68	4.64	4.31
P/FCF Ratio	-5.41	-24.35	-4.71	-2.06	-3.27	-1.43
P/OCF Ratio	-5.45	-25.74	-4.76	-2.08	-3.31	-1.46
EV/Sales Ratio	4.33	2.93	152.76	1.56	11.39	10.02
EV/EBITDA Ratio	-11.31	-6.78	-3.69	-0.57	-1.62	-0.87
EV/EBIT Ratio	-9.69	-5.71	-3.46	-0.52	-1.52	-0.83
EV/FCF Ratio	-4.33	-16.16	-4.32	-0.72	-1.95	-0.83
Debt / Equity Ratio	1.20	0.81	-0.83	0.92	0.35	0.51
Debt / EBITDA Ratio	-0.57	-0.66	-0.25	-0.27	-0.21	-0.18
Debt / FCF Ratio	-0.22	-1.56	-0.29	-0.33	-0.25	-0.17
Quick Ratio	1.09	1.19	1.24	2.35	1.77	1.67
Current Ratio	1.19	1.26	1.38	2.53	1.90	1.57
Asset Turnover	0.48	0.47	0.02	0.19	0.08	0.04
Return on Equity (ROE)	911.10%	263.50%	3458.50%	-356.80%	-289.10%	-144.60%
Return on Assets (ROA)	-26.30%	-23.70%	-91.40%	-57.10%	-58.10%	-53.50%
Return on Capital (ROIC)	-129.05%	-94.77%	2176.27%	-203.51%	-136.84%	-216.37%
Earnings Yield	-9.69%	-11.50%	-26.60%	-66.17%	-39.05%	-70.46%
FCF Yield	-21.81%	-4.11%	-21.21%	-48.48%	-30.56%	-69.91%
Buyback Yield / Dilution	-26.67%	-34.55%	-52.16%	-32.11%	-15.83%	-16.90%
Total Shareholder Return	-26.67%	-34.55%	-52.16%	-32.11%	-15.83%	-16.90%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).